Sartorius Stedim Biotech launches Integrated Solutions online resource center
New website will support clients in developing and implementing entire single-use bioprocesses.
Sartorius Stedim Biotech has launched its Integrated Solutions website, an online resource and information centre to support its clients as they develop and implement entire single-use or hybrid biomanufacturing processes.
The new website is designed to assist clients in the implementation of flexible, scalable and cost-efficient bioprocesses by utilizing the tools, technologies, support and expertise available from Sartorius Stedim Biotech. To allow clients to better understand the effectiveness with which Integrated Solutions can be applied to their bioprocesses a comprehensive portfolio of case studies are available from companies such as Boehringer Ingelheim, Wuxi AppTec, Mabion, DMBio and Bayer.
The biopharmaceutical industry is being forced to adapt to changing and challenging market conditions. Reducing costs and increasing process optimization are becoming increasingly important due to pressures from healthcare providers and competition from biosimilars. Sartorius Stedim Biotech’s new Integrated Solutions website describes how the company addresses these challenges through partnering with clients to design and develop entire single-use and hybrid processes for the manufacture of biopharmaceuticals. Process development activities are coordinated by a team of process development consultants utilizing an array of technologies and software tools while the design and engineering of the large-scale bioprocess is performed by a separate, dedicated team that have successfully completed over 100 fully single-use projects.
Ensuring clients benefit from the shortest time to market, Sartorius Stedim Biotech is using the Integrated Solutions website to showcase its new ‘mAb Process Platform’. The new platform is a result of the company’s innovative ‘Process4Success’ initiative which seeks to leverage both novel single-use processing technologies and the expertise within the organization to define sequences of unit operations that can be combined to create an entire bioprocess line.
Multiple client testimonials are available on the new resource center describing how the Integrated Solutions approach has already been successfully applied to a number of diverse collaborative projects. For example, speaking of a recent collaboration between Sartorius Stedim Biotech and Boehringer Ingelheim, Jan Feuser (Head of Clinical Supply Facility Downstream at Boehringer Ingelheim) said: “The ability to work across different sites at a global scale with one Boehringer Ingelheim project team and one Sartorius project team, truly enabled the success of the project.“
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...